
Charles Schwab (SCHW) is navigating a complex market with shifting interest rates and competition, yet maintains a strong financial position, evidenced by a perfect Piotroski Score and 37 years of dividend payments. The company reported EPS of $3.30 for the last twelve months, with projections of $4.26 for fiscal year 2025, and is focused on organic growth, aiming for a 5-7% annual NNA increase, while also exploring new ventures like cryptocurrency trading; analysts project $20 billion in excess capital by 2027 for potential shareholder returns, though interest rate sensitivity and competitive pressures remain key challenges.
The Charles Schwab Corporation (SCHW) demonstrates robust financial health, evidenced by a perfect Piotroski Score of 9 and a 37-year track record of consistent dividend payments. The company's market capitalization stands at $161.04 billion as of May 2025, with InvestingPro assigning a "GOOD" financial health score. Recent performance includes strong earnings per share (EPS) of $3.30 for the last twelve months, with analysts projecting a rise to $4.26 for fiscal year 2025, supported by a favorable PEG ratio of 0.68. This growth trajectory notably outpaces the average growth rates for brokers (15%) and the broader Financial Select Sector SPDR Fund (XLF) (10%). The successful integration of TD Ameritrade has expanded Schwab's customer base, with 1.3 million traders on its platform generating higher Net New Assets (NNA) and Return on Client Assets (ROCA) compared to retail households. Management is targeting a 5-7% annual NNA growth rate, expanding securities lending, exploring new product offerings like cryptocurrency trading (contingent on regulatory approval), and pursuing aggressive capital management, with projections of approximately $20 billion in excess capital by the end of 2027 for shareholder returns. Despite these strengths, including a diversified business model and strong brand recognition, SCHW faces challenges from interest rate sensitivity, intense competition from traditional brokers and fintech firms which could lead to fee compression, potential regulatory changes, and macroeconomic uncertainties. The stock is trading near its 52-week high of $89.84, reflecting a 20.54% year-to-date return, with analyst price targets ranging from $74.00 (Barclays, Nov 2024) to $102.00 (Citi Research, Apr 2025).
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
strongly positive
Sentiment Score
0.75
Ticker Sentiment